Bromocriptine Mesilate Tablets

Effects and efficacy:
Bromocriptine mesylate tablets can be used to treat some diseases of the endocrine system and nervous system.
Usage and dosage:
Bromocriptine mesylate tablets should be taken orally during meals. The dosage varies according to the disease and should be followed according to the doctor’s advice. Irregular menstruation and female infertility can be treated with 1.25 mg once, 2 to 3 times a day as needed. If the effect is not significant, the dose can be gradually increased to 2.5 mg once, 2 to 3 times a day. Uninterrupted treatment until the menstrual cycle returns to normal and/or ovulation re-occurs. If necessary, continuous treatment can be performed for several cycles to prevent recurrence. Male hyperprolactinemia can be treated with 1.25 mg once, 2 to 3 times a day as needed, and gradually increased to 5 to 10 mg a day. The specific plan should be determined based on clinical efficacy and side effects. The recommended starting dose for acromegaly is 1.25 mg once, 2 to 3 times a day. According to clinical reactions and adverse reactions, gradually increase to 10 to 20 mg a day. For the first day of medication for lactation suppression and early postpartum mastitis, take 1.25 mg each morning and evening at breakfast and dinner, followed by 2.5 mg/time, twice a day, for 14 consecutive days. For lactation suppression, treatment should be started within a few hours after delivery or abortion to prevent lactation, but should not be started before vital signs stabilize. Occasionally, there will be a small amount of lactation 2-3 days after the treatment is stopped. At this time, the original dose can be used to repeat the treatment for 1 week. Antibiotics can be used in combination with postpartum mastitis under the guidance of a doctor. Prolactinoma 1.25 mg/time, 2 to 3 times a day, gradually increase to several tablets or capsules per day to ensure that the prolactin level in plasma is controlled. For people aged 11 to 17, the starting dose is 1.25 to 2.5 mg. The dose is gradually increased according to tolerance to control the prolactin level in plasma. The recommended maximum daily dose is 10 mg. For Parkinson’s disease, in order to obtain the best tolerance, it should start with a low dose of 1.25 mg per day, and it is recommended to take the medicine at night in the first week. The daily dose can be increased by 1.25 mg per week until the minimum effective dose. The daily dose can be taken in 2 to 3 times. If satisfactory efficacy is not achieved within 6 to 8 weeks, try to increase the daily dose by 2.5 mg per week. During the dose adjustment period, if adverse reactions occur, the dose should be reduced for at least one week; after the adverse reactions disappear, the dose should be increased as soon as possible. For those who develop movement disorders during levodopa treatment, the dose of levodopa should be reduced before using this product. After obtaining satisfactory efficacy, the dose of levodopa should be gradually reduced.
Adverse reactions:
Taking bromocriptine mesylate tablets may have the following adverse reactions. Mental abnormalities: confusion, mental agitation, hallucinations are uncommon, psychotic symptoms and insomnia are rare, and impulse control disorders may occur. Nervous system abnormalities: headache, drowsiness, dizziness are common, movement disorders are uncommon, sensory abnormalities are rare, and sudden sleep is rare. Eye abnormalities: visual impairment and blurred vision are rare. Abnormalities of the ear labyrinth: tinnitus is rare. Cardiovascular abnormalities: pericardial effusion, constrictive pericarditis, tachycardia, bradycardia, other arrhythmias are rare, and valvular fibrosis is rare. Vascular abnormalities: hypotension, postural hypotension (rarely leading to syncope) are uncommon, and reversible pallor of fingers and toes due to cold is rare. Respiratory system, thoracic and mediastinal abnormalities: nasal congestion is common, and pleural effusion, pleural fibrosis, pleurisy, pulmonary fibrosis, and dyspnea are rare. Gastrointestinal abnormalities: nausea, constipation, and vomiting are common, dry mouth is uncommon, and diarrhea, abdominal pain, retroperitoneal fibrosis, gastrointestinal fibrosis, gastrointestinal ulcers, and gastrointestinal bleeding are rare. Skin and subcutaneous tissue abnormalities: allergic dermatitis and alopecia are uncommon. Musculoskeletal and connective tissue abnormalities: muscle cramps are uncommon. General discomfort: fatigue is uncommon, peripheral edema is rare, and symptoms similar to malignant syndrome after abrupt drug withdrawal are rare. Others: There have been case reports of patients abroad who developed pathological gambling, increased libido and hypersexuality after using dopamine receptor agonists to treat Parkinson’s disease, especially at high doses, which can generally be reversed after reducing the therapeutic dose or stopping the drug.
Drug contraindications:
Allergic to this product is prohibited. It is prohibited during lactation. It is prohibited during pregnancy. It is prohibited for driving.